Want to join the conversation?
$CELG 2Q15 Call: Received approval for REVLIMID for the expanded use in patients newly diagnosed with multiple myeloma in the U.S. and Europe. Received approval for POMALYST in Japan for the treatment of relapsed and refractory multiple myeloma (RRMM).
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!